Performance Evaluation of the BD SARS-CoV-2 Reagents for the BD MAX System
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Nucleic acid amplification testing (NAAT) for SARS-CoV-2 is the standard approach for confirming COVID-19 cases. This study compared results between two emergency use authorization (EUA) NAATs, with two additional EUA NAATs utilized for discrepant testing.
Article activity feed
-
-
SciScore for 10.1101/2021.05.12.21257120: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Field Sample Permit: The second study involved post-market clinical testing and involved 1,376 specimens from four collection sites in the U.S. (Table S1).
IRB: The study protocol was approved by the Advarra Institutional Review Board and de-identified specimens from collection sites were used for testing.
Consent: Written, informed consent was obtained prior to any trial-related procedures.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
No key resources detected.
Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible …
SciScore for 10.1101/2021.05.12.21257120: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Field Sample Permit: The second study involved post-market clinical testing and involved 1,376 specimens from four collection sites in the U.S. (Table S1).
IRB: The study protocol was approved by the Advarra Institutional Review Board and de-identified specimens from collection sites were used for testing.
Consent: Written, informed consent was obtained prior to any trial-related procedures.Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
No key resources detected.
Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-
